Invitro International
InVitro International, Inc. develops test kits for non-animal testing applications in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivi… Read more
Market Cap & Net Worth: Invitro International (IVRO)
Invitro International (OTCQB:IVRO) has a market capitalization of $2.00 Million ($2.00 Million) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #48379 globally and #14872 in its home market, demonstrating a 11.11% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Invitro International's stock price $0.09 by its total outstanding shares 22259809 (22.26 Million).
Invitro International Market Cap History: 2015 to 2025
Invitro International's market capitalization history from 2015 to 2025. Data shows growth from $224.82K to $2.00 Million (24.28% CAGR).
Invitro International Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Invitro International's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.97x
Invitro International's market cap is 1.97 times its annual revenue
0.69x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
1003.34x
Invitro International's market cap is 1003.34 times its annual earnings
363.13x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $394.00K | $884.25K | $122.90K | 0.45x | 3.21x |
| 2017 | $890.39K | $855.62K | $47.84K | 1.04x | 18.61x |
| 2019 | $1.67 Million | $1.05 Million | $70.67K | 1.59x | 23.62x |
| 2020 | $1.94 Million | $1.10 Million | $49.89K | 1.75x | 38.81x |
| 2021 | $5.56 Million | $1.00 Million | $95.99K | 5.55x | 57.97x |
| 2022 | $2.23 Million | $853.51K | $21.28K | 2.61x | 104.62x |
| 2023 | $1.56 Million | $792.63K | $1.55K | 1.97x | 1003.34x |
Competitor Companies of IVRO by Market Capitalization
Companies near Invitro International in the global market cap rankings as of March 18, 2026.
Key companies related to Invitro International by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Invitro International Historical Marketcap From 2015 to 2025
Between 2015 and today, Invitro International's market cap moved from $224.82K to $ 2.00 Million, with a yearly change of 24.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.00 Million | +21.29% |
| 2024 | $1.65 Million | +6.00% |
| 2023 | $1.56 Million | -30.00% |
| 2022 | $2.23 Million | -60.00% |
| 2021 | $5.56 Million | +187.36% |
| 2020 | $1.94 Million | +16.00% |
| 2019 | $1.67 Million | +87.50% |
| 2018 | $890.39K | 0.00% |
| 2017 | $890.39K | +125.99% |
| 2016 | $394.00K | +75.25% |
| 2015 | $224.82K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Invitro International was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.00 Million USD |
| MoneyControl | $2.00 Million USD |
| MarketWatch | $2.00 Million USD |
| marketcap.company | $2.00 Million USD |
| Reuters | $2.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.